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Osteosarcoma is the most common malignant bone tumor in dogs and, like its human orthologue, is characterized by aggressive local behavior
and high metastatic rates. The Scottish deerhound is a breed of dog with a N15% incidence of osteosarcoma and represents an excellent
spontaneously occurring large-animal model of the human disease. We modeled the transmission of the osteosarcoma phenotype in a population of
over 1000 related deerhounds ascertained as part of a prospective health study. Variance component analysis, segregation analysis, and linear
modeling were performed to evaluate heritability, to infer the presumptive transmission model, and to identify covariate effects for this phenotype
within the breed, respectively. Based on variance component analysis, heritability (h2) was estimated to be 0.69. Six transmission models were
analyzed by segregation analysis; based on Akaike's information criteria, the most parsimonious model was the Mendelian major gene model with
dominant expression. Linear modeling identified gender and genotype as significant predictors of disease outcome. Importantly, duration of
gonadal hormone exposure, weight, and height at maturity were not significant predictors of outcome. Inheritance of the putative high-risk allele
was thus associated with N75% risk of disease occurrence compared to the b5% baseline risk. These results support the hypothesis that a major
gene with a dominant effect explains most of the osteosarcoma phenotype within the Scottish deerhound.
© 2007 Elsevier Inc. All rights reserved.Keywords: Cancer; Osteosarcoma; Canine; Segregation; HeritabilityOsteosarcoma (osteogenic sarcoma; OSA) is the most
common (N85%) malignant bone tumor of dogs and represents
an excellent model for osteogenic sarcoma in humans [1]. In the
United States, approximately 8000 canine and 400 human cases
of osteosarcoma are diagnosed each year [2,3]. In the canine
population, large and giant breeds of dogs are at increased risk
for the development of OSA; together these breeds account for
the majority (N80%) of reported cases [4].
The Scottish deerhound is a giant-breed dog first recognized
by the American Kennel Club (AKC) in 1935 (Fig. 1A). The
overall breed-specific incidence of OSA in the deerhound has
been estimated to be greater than 150 cases per 1000 dogs (com-
pared to 7 cases per 100,000 dogs in the general dog population)
[4,5]. Clinical signs seen in affected dogs include lameness,⁎ Corresponding author. Fax: +1 865 974 5554.
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doi:10.1016/j.ygeno.2007.05.001swelling in an extremity, and in some cases pathologic fracture. A
presumptive diagnosis of OSA can be made through a com-
bination of signalment, clinical presentation, and radiographic
findings (Fig. 1B). Pathologic tissue evaluation, however, is
needed to confirm the diagnosis. Given the high incidence of
OSA within a relatively small, closely related population, it is
likely that a major gene for the disease exists within this breed.
OSA in dogs and humans has many similarities, including the
predilection for metaphyseal regions of long bones, high-grade
malignancy, a high rate of metastasis, and the lung as the most
common site of metastasis [1]. Because of the successful com-
bination of adjuvant chemotherapy with local therapies, the
survival rates in both dogs and humans have significantly
improved. Despite these advances, no preventative and very few
prognostic strategies have been implemented because the mole-
cular events driving tumorigenesis in OSA remain unknown in
both species. Identification of risk factors that correlate with
Fig. 1. (A) Photograph of an unaffected juvenile female Scottish deerhound. (B) Lateral radiograph of the distal forelimb from an adult deerhound exhibiting the classic
findings seen in osteosarcoma. Radiographic features include bony lysis, periosteal reaction, and a cortical defect from a previous bone biopsy. Circumferential soft
tissue swelling is also present at the tumor site (arrow).
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greatly improve our understanding of this disease.
Numerous molecular studies have been undertaken in recent
years to elucidate the etiology of human and canine OSA [6–
10]. It was evident from the earliest studies of DNA ploidy that
the karyotypes in human OSA are usually complex, particularly
in high-grade tumors. Loss-of-heterozygosity screening has
identified several chromosomal regions associated with high
frequencies of allelic loss. Comparative genomic hybridization
has also been used to identify regions of genomic amplification
in human-origin tumors. In contrast, much less information
exists regarding the cytogenetic, genetic, or molecular changes
underlying the development of canine OSA. The few studies to
date have used immunohistochemistry to identify genes with
altered expression in canine OSA, including TP53, RB1,
MDM2, PTGS2, and PTEN. The prognostic significance of
these findings has not been shown [8–10].
Several veterinary reports [3,4,11,12] have examined the
incidence of canine osteosarcoma in an attempt to identify risk
factors for disease. Two of these reports [4,11] have suggested
adult body size to be the strongest correlate of risk for osteo-
sarcoma development. As noted previously, certain breeds [4]
also have a well-known increased risk for osteosarcoma. Actual
breed-specific incidence, however, has been reported only for
the Rottweiler at 12.6% [12]. Studies have also suggested
gender to be a risk factor; although contradictory informationexists in the literature [3,4,12,13]. A recent report [12] has
evaluated the role of gonadal hormone exposure in the
development of osteosarcoma. Results from this study sug-
gested that overall lifetime risk for bone sarcoma formation was
inversely related to total gonadal hormone exposure. No studies
to date have evaluated the combined effects of age, gender,
height, weight, and familial correlates on the risk of bone tumor
formation.
The objectives of this study were to estimate the heritability
of osteosarcoma by variance component analysis, to use
complex segregation analysis to identify the presumptive
mode of inheritance, and to use a generalized linear model to
identify predictors of risk for osteosarcoma development within
purebred Scottish deerhounds. Further knowledge of the genetic
factors underlying canine OSA could provide important
information regarding mechanisms of tumorigenesis, prognos-
tic biomarkers, and potential targets for novel gene therapy (for
both canine and human OSA).
Results
Descriptive analysis
There were 1057 dogs identified through five affected
probands. Based on AKC registrations [23], this population
represents ∼21% of all registered deerhounds during the years
Table 1A
Descriptive statistics for 1057 dogs in 314 families analyzed in the segregation
analysis of osteosarcoma (mean±standard deviation)
Total population Males (n=479) Females (n=578) All
Total individuals 1057
Affected 74 137
Unaffected 382 412
% Affected 16% 25%
Missing 23 29
Probands 4 1
Sibships 314
Sibship size 1–11 (3.0±1.9)
Inbreeding loops 187
Inbreeding
coefficient
0.032
Age (years) 0.5–14.9 a (6.6±2.8) 0.5–14.9 a (7.4±3.0)
Age of onset
(years)
2–13.9 a (7.0±2.0) 2.5–13.0 a (8.1±2.5)
a Significant difference noted between gender-specific distributions
(pb0.001).
Table 1B
Subgroup statistics for 274 dogs analyzed in covariate analysis of weight,
height, and length of time intact (mean±standard deviation)
Subgroup Males (n=140) Females (n=134)
Total individuals
Affected 22 36
Unaffected 118 98
Missing 0 0
Age (years) 1.2–11.5 a (7.5±2.5) 3.7–13.9 a (9.0±2.1)
Age of onset (years) 6.2–7.9 a (7.0±1.0) 6.5–9.9 a (8.4±1.3)
Height (in.)
Affected 31.5–34.5 a (32.0±0.7) 29.0–32.5 a (30.5±1.0)
Unaffected 30.0–35.0 a (32.7±1.1) 28.5–33.5 a (30.8±1.0)
Weight (lb)
Affected 95.0–118.0 a (109±8.2) 75.0–105.0 a (92.0±7.6)
Unaffected 82.0–125.0 a (106±9.5) 65.0–100.0 a (90.0±8.4)
Length of time intact (years)
Affected 1.5–13.9 (6.4±3.2) 0.5–13.0 (7.2±3.5)
Unaffected 0.5–14.9 (6.6±2.8) 0.5–14.9 (7.4±3.0)
a Significant difference noted between gender-specific distributions
(pb0.001).
356 J.C. Phillips et al. / Genomics 90 (2007) 354–3631975–2003. A single pedigree was constructed to include all
1057 dogs: 479 males and 578 females (Table 1A). The
pedigree contained 314 sibships of average size 3 (SD=1.9) and
range 1–11. A total of 187 inbreeding loops were identified,
with an average inbreeding coefficient of 0.032 estimated using
the kinship matrices option of MENDEL 6.01. Due to the
graphical complexity of this pedigree, only a small subset of the
pedigree is shown in Fig. 2.
Of these dogs, 211 were confirmed affected, 794 were
unaffected at the time of exam, and 52 had unknown health
status or were lost to follow-up. The absolute percentage of
affected dogs among all dogs with known health status was 21%
(211/1005). Affected dogs ranged in age from 2 to 13.9 years
with a mean age of onset of 7.7 years. Affected dogs were also
significantly older than unaffected dogs (7.7 vs 7.0 years,
p=0.003); suggesting age to be an important predictor of health
status.
Gender-specific differences were present in this population.
Overall, male dogs were significantly younger than female
dogs (6.6 vs 7.4 years, pb0.001). Age of onset also variedFig. 2. Subset pedigree of 57 Scottish deerhounds with known affected status, drawn u
pedigree symbols are used. Affected individuals are represented by filled symbols. M
diagonal lines through their symbols.significantly between the genders, with affected male dogs
significantly younger than affected female dogs (7.0 vs 8.1
years, p=0.001). The female-specific incidence of osteosar-
coma was higher than the male-specific incidence (25% vs
16%). Information on height, weight, and length of time
sexually intact was available for 274 dogs (Table 1B). Based
on gender and affected status this subgroup was not
significantly different from the larger population (data not
shown). Males in this subgroup were significantly taller than
females (33 vs 31 in., pb0.0001) and weighed more than the
females (107 vs 91 lb, pb0.0001) at maturity. However, there
was no significant difference in height or weight between
affected and unaffected individuals of either male or female
gender in this subgroup (pN0.4 for each comparison,
respectively). Finally, length of time sexually intact was not
significantly different between affected and unaffected dogs or
between genders. Together, these results suggest that age and
gender are significant predictors of health status in this
population, while height, weight, and length of time sexually
intact are not.sing the Cyrillic pedigree software (Cyrillic 2.1.3; Cherwell Software). Standard
ultiple inbreeding (bold lines) and mating loops are present. Deceased dogs have
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The results of variance component analysis are listed in
Table 2. Models with and without different variance compo-
nents were compared to the most general model (Model 4). The
hypothesis of no genetic variance was rejected in favor of
models including a genetic component (Models 1 and 2 vs
Models 3 and 4). Addition of covariates for gender significantly
improved the fit of the variance model (Model 1 vs Model 2).
Addition of a covariate for age, however, did not significantly
improve the variance model (data not shown). Inclusion of a
dominance (nonadditive) variance component (Model 3 vs
Model 4) significantly improved the variance model (p=0.008,
χ2 =7.0, df=1); together, these nonadditive components
accounted for 30% of the total phenotypic variance. The final
model thus included both additive and dominance variances
along with a covariate for gender.
Segregation analysis
Parameter estimates and likelihoods from the segregation
analysis using the software jPAP [15] are presented in Table
3. This software does not include an option for the
incorporation of nongenetic covariates; however, it does
allow for the categorical variables such as gender. The
software also allows for the addition of within-genotype
correlations; the presence of which implies a mixed (major
gene + polygenic component) model. Therefore, a total of
seven models were analyzed, each with gender-specific
disease penetrance and transmission probabilities and with
correction for ascertainment bias. The fully parameterized
model (Model 7) also included within-genotype correlationsTable 2
Variance component analysis and heritability estimates with modeling of covariate e
Model 1
Environmental
Model 2 Environment
w/ covariates
Parameter means
GRAND 0.2100±0.0128 0.2059±0.0128
Female gender 0.0436±0.0128
Male gender −0.0436±0.0128
Variance components
Additive NA
Dominance NA
Environmental 0.1659±0.0074 0.1640±0.0073
Total 0.1659 0.1640
Heritability NA NA
Summary statistics
ln(L) 400.3 406.0
Parameters 2 3
df 3 2
χ2 189.6 178.2
p value b0.001 b0.001
Parameters are estimated using the variance component option of MENDEL [15] s
model (Model 4) to submodels and were obtained by using a likelihood ratio test. The
log-likelihood; df, degrees of freedom.
a Model 3 heritability value corresponds to the narrow-sense heritability (h2=σa/
b Model 4 heritability value corresponds to the broad-sense heritability (H2=σa+modeled as variance components. Addition of these within-
genotype components to the general model, however, failed to
improve the fit significantly (Model 7 vs Model 6, p=0.17);
these components were thus not included in any submodels
(Models 1–6).
As shown in Table 3, the No major locus and Envi-
ronmental models were rejected against the general model
(pb0.0001). Based on the likelihood ratio test (LRT), there
was no significant difference between the Mendelian reces-
sive (p=0.39), dominant (p=0.90), or codominant (p=0.76)
model and the fully parameterized model (Model 7). Not
surprisingly, both general models provided penetrance esti-
mates and transmission probabilities that were very similar to
the Mendelian dominant model (Table 3). Finally, based on
Akaike's Information Criteria (AIC), the Mendelian dominant
model proved to be the most parsimonious. Inheritance of a
putative high-risk allele (qA=0.128) predicted gender-specific
risks (i.e., penetrance) for osteosarcoma development of 72
and 99% for males and females, respectively. The esti-
mated baseline (i.e., sporadic) risk for osteosarcoma deve-
lopment among individuals without the high-risk allele was
∼3–4%.
Linear modeling
Results of linear modeling of the osteosarcoma phenotype
with correction for ascertainment bias are summarized in
Table 4. Inclusion of a major gene effect (two or three
ousiotypes) provided a significantly better fit over the No
major gene model (Models 2–4 vs 1). To refine the
Mendelian transmission model, and determine the effects of
covariates on phenotype, three autosomal Mendelian modelsffects for gender (mean±standard deviation)
al Model 3 Environmental +
additive w/ covariates
Model 4 Environmental +
additive + dominance
w/ covariates
0.2025±0.0260 0.2033±0.0264
0.0389±0.0116 0.0368±0.0114
−0.0389±0.0116 −0.0368±0.0114
0.1203±0.0138 0.1230±0.0155
NA 0.0529±0.0226
0.0541±0.0075 0.0022±0.0223
0.1744 0.1782
0.69 a 0.99 b
491.6 495.1
4 5
1 –
7.0 –
0.0082 –
oftware and maximum likelihood methods. p values compare the most general
null hypothesis of no heritability is represented in Models 1 and 2. ln(L), natural
σT).
σd/σT).
Table 3
Segregation analysis of osteosarcoma in 1057 Scottish deerhounds
Parameter Model 1
No major
locus
Model 2
Environmental
Model 3
Mendelian
recessive
Model 4
Mendelian
dominant
Model 5
Mendelian
codominant
Model 6
General
Model I
Model 7
General
Model II a
qA
b [1.0] 0.098 0.499 0.128 0.131 0.131 0.093
qB 0.902 (0.009) 0.501 (0.03) 0.872 (0.02) 0.869 (0.02) 0.869 (0.02) 0.907 (0.02)
ψAA
c 0.249 0.016 0.015 0.015 0.009
ψAB
c 0.500 0.224 0.212 0.212 0.168
ψBB
c 0.251 0.760 0.773 0.773 0.823
τAA male 0.903 (0.009) [0] [0] [0] 0.059 (0.36) 0.270 (0.42)
τAB male =τAA [0.5] [0.5] [0.5] 0.514 (0.02) 0.505 (0.02)
τBB male =τAA [1.0] [1.0] [1.0] 0.995 (0.02) 1.0
d
τAA female 0.903 (0.009) [0] [0] [0] 0.246 (0.65) 0.018 (0.50)
τAB female =τAA [0.5] [0.5] [0.5] 0.481 (0.02) 0.501 (0.02)
τBB female =τAA [1.0] [1.0] [1.0] 1.0
d 1.0 d
βAA male 0.184 (0.02) 1.0
d 0.750 (0.08) 0.718 (0.08) 1.0 d 1.0 d 0.658 (0.06)
βAB male =βAA male 0.998 (0.01) 0.0
d =βAA 0.669 (0.09) 0.694 (0.09) 0.691 (0.06)
βBB male =βAA male 0.0
d =βAB 0.035 (0.02) 0.034 (0.01) 0.028 (0.02) 0.109 (0.04)
βAA female 0.267 (0.02) 0.999 (0.01) 0.944 (0.05) 0.995 (0.05) 1.0
d 1.0 d 0.947 (0.02)
βAB female =βAA female 0.999 (0.01) 0.012(0.01) =βAA 0.980 (0.06) 0.986 (0.06) 0.999 (0.02)
βBB female =βAA female 0.101 (0.03) =βAB 0.042 (0.02) 0.039 (0.02) 0.041 (0.02) 0.134 (0.04)
Heritability NA NA [0] [0] [0] [0] 1.0 d
Statistics
Parameters 2 7 5 5 7 13 14
df 12 7 9 9 7 1 –
−2 ln(L) 753.72 753.73 644.50 638.77 637.75 636.90 634.99 e
AIC 777.72 767.73 654.50 648.77 651.75 662.90 662.99
p value b0.0001 b0.0001 0.39 0.93 0.91 0.17 Reference
Parameters were estimated using jPAP [13] software and maximum likelihood methods. Submodels are compared to the most general model (Model 7) using a
standard likelihood ratio test. Models are compared to each other using AIC. Numbers in brackets [ ] are fixed in this analysis. Standard errors are listed in
parentheses ( ). qA, frequency of putative high-risk allele A. ψi/j, genotype probability for individual with type i/j assuming Hardy–Weinberg equilibrium. τi/j,
transmission probability for individual with type i/j. βi/j, gender-specific penetrance for individual with type i/j. The parameter Heritability refers to the within-
genotype variance of the genetic model. df, degrees of freedom. −2 ln(L), minus twice the log-likelihood. AIC, Akaike's information criteria. p value, comparing
general model with submodels assuming χ2 distribution.
a General Model II includes an estimated within-genotype parameter modeled as variance components.
b Frequency of high-risk allele (qA) calculated as 1−qB.
c Values are calculated from allele frequencies assuming Hardy–Weinberg equilibrium.
d Boundary maximum verified.
e Reference value used to compare submodels.
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Mendelian recessive model appeared to be a poor fit with
high standard errors and was rejected against the most general
model (pb0.0001). Based on AIC, the Mendelian model with
dominant transmission appeared to be the most parsimonious
model. The frequency of the high-risk allele in this model is
qA=0.118.
Covariate effects of gender, age, genotype, height and
weight at maturity, and length of gonadal hormone exposure
were also estimated by linear modeling. Only gender and
genotype significantly improved the fit of the data in this
population and were therefore included in all analyses.
Assuming the Mendelian dominant model of transmission,
female gender increased the relative risk (or odds ratio) of
affectation by 2.8 in comparison to males. Under the dominant
model, the penetrance (probability of affectation) for indivi-
duals carrying the high-risk allele (genotypes ψAA and ψAB)
was 77 and 90%, for males and females, respectively. The
baseline probabilities of being affected for individuals without
the high-risk allele were 1.7 and 4.5% for males and females,
respectively.Discussion
Several reports [3,4,11] have suggested that height, weight,
and gender are significant modifiers of risk for the development
and/or the biological behavior of osteosarcoma in large-breed
dogs. More recently, a nonrandomized retrospective cohort
study in the Rottweiler breed [12] suggested that duration of
gonadal hormone exposure was predictive for both the
development of bone cancer and its clinical behavior. Other
covariates such as height, weight, age, or gender were not found
to be predictive of either tumor development or behavior within
the Rottweiler breed. In this deerhound population, covariates
for height, weight, age, gender, and length of gonadal hormone
exposure were examined. While the descriptive analysis
identified age and gender as important covariates, gender was
the only covariate that proved to be predictive for bone tumor
formation in multivariate analysis (segregation analysis and
linear modeling). These apparent differences in risk factors may
be population specific (i.e., breed or subpopulation within
breed) or secondary to other confounding factors. This
population of deerhounds has an average inbreeding coefficient
Table 4
Linear modeling of osteosarcoma in 1057 Scottish deerhounds
Parameter Model 1 Model 2 Model 3 Model 4
No major
gene (H0)
Recessive Dominant Genotypic
qA 0.120 (0.03) 0.834
a 0.118 (0.02) 0.117 (0.02)
ψAA – 0.696 0.014 0.014
ψAB – 0.276 0.206 0.206
ψBB – 0.028 0.780 0.780
βo −1.375 (0.30) −18.59 (330.1) −0.925 (0.29) −0.091 (0.61)
βAA – −19.31 (330.1) 2.638 (0.23) 1.633 (1.50)
βAB – 19.31 (330.1) =βAA 1.833 (0.91)
βBB – =βAB −2.638 (0.23) −3.466 (0.67)
Covariate
Male −0.266 (0.12) −0.598 (0.2) −0.521 (0.20) −0.521 (0.20)
Female 0.266 (0.12) 0.598 (0.2) 0.521 (0.20) 0.521 (0.20)
Statistics
Parameters 3 4 4 6
df 3 2 2 –
−2 ln(L) 1018.52 895.07 875.86 875.85
χ2 142.67 19.22 0.01 –
AIC 1024.52 903.07 883.86 887.85
p value b0.0001 b0.0001 0.995 Reference
Parameter estimates were calculated using the penetrance option of MENDEL
[15] software and maximum likelihood methods. p values were obtained by
comparing submodels to the most general model (Model 4) using a standard
likelihood ratio test and assuming a χ2 distribution. Models are further com-
pared to each other using Akaike's information criteria (AIC). Standard errors
are listed in parentheses. qA, frequency of putative high-risk allele A. ψi/j,
genotype probability for individual with type i/j assuming Hardy–Weinberg
equilibrium. βi/j, genotype offset for individual with type i/j. df, degrees of
freedom. −2 ln(L), minus twice the log-likelihood.
a Standard error could not be calculated.
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more diverse populations such as the Rottweiler. Increased
levels of inbreeding serve to reduce genetic variability and thus
increase major gene effects (a process referred to as trait
“Mendelization”), while decreasing the significance (i.e.,
variability) of polygenic effects such as height, weight, and
duration of gonadal hormone exposure. Also, this population of
dogs is enriched for dogs affected with osteosarcoma; this
enrichment can make it even more difficult to quantify poly-
genic risk factors [24].
It is also possible that the covariate effects of height and
weight are confounded by gender-specific differences in disease
incidence. Notably, the incidence of osteosarcoma in female
dogs is ∼1.6 times higher than the incidence in male dogs.
Possible origins for this gender predilection include sampling
bias, or alternatively, one could postulate that a portion of male
deerhounds die of unrelated causes (i.e., nonosteosarcoma) at a
younger age, on average, than female deerhounds. In reference
to sampling bias, ascertainment was performed through disease
phenotype and covariates were not involved in the sampling
process; as such, they should not require correction. Further-
more, the population distribution with respect to these
covariates (age, gender, height, and weight) is not significantly
different from that previously reported [5]. Support for the
alternate “early death” hypothesis is found in the observation
that males appear to be more susceptible to heart-disease-related
deaths, which occur more frequently (27% vs 16%) and at ayounger age in males than in females (7.6 years in males vs 8.9
years in females) [5]. These “early” deaths serve to eliminate
potentially affected male carriers from the population prior to
the onset of their cancer; while they are phenotypically
unaffected. The result is a significant age differential between
unaffected males and females (6.6 vs 7.0 years, p=0.0009) and
a skewing of gender-specific disease incidences as described
here and transmission/penetrance estimates as described below.
The heritability of the osteosarcoma phenotype within the
deerhound breed was evaluated by variance component
analysis. The results demonstrated the presence of a significant
additive and dominance variance component. The existence of a
large dominance variance suggests the presence of single
(dominant) high-risk allele within this population. On a theo-
retical level, there are two problems with the variance com-
ponent analysis. First, the likelihood ratio test used to compare
models assumed differences to be asymptotically distributed as
a χ2. The presence of a lower bound of 0, inherent in the model,
changes the distribution of the likelihood ratio test to an even
mixture of a point mass at zero and a χ2 with 1 degree of
freedom [25]. Thus the real p value for comparing models with
and without a dominance component is likely different from the
estimated value of 0.008. Second, the variance component
model used herein assumed the absence of inbreeding. The
presence of inbreeding results in a more complex dominance
relationship that cannot be modeled with currently available
software. Furthermore, inbreeding and the resultant complex
population structure also necessitated population subdivision
prior to statistical analysis. Due to this subdivision we also
cannot rule out the possibility of more than one dominantly
acting gene (contributing to the dominance variance) in this
population; although given a relatively small and inbred
population, a single locus is most likely. In summary, while
variance component analysis identified a significant additive
effect in this population (h2 =0.69), the true significance of a
nonadditive (dominance) effect is unknown.
Transmission of the putative high-risk allele was studied
using both segregation analysis and linear modeling. Results
from each approach were consistent with the presence of a
dominant major gene with gender-specific transmission and
penetrance parameters. Specifically, in segregation analysis
comparison of parameter estimates in the Mendelian dominant
model to those of the unrestricted (general) model agrees
surprisingly well (Table 3), providing strong support to the
dominant transmission model. High standard errors, however,
were noted for the transmission parameters associated with the
affected homozygote in the general model. These likely reflect
the presence of relatively few affected homozygotes, which are
required to differentiate accurately the three genotypes.
Mendelian models avoid this difficulty by requiring the pre-
sence of only two discernible genotypes. In linear modeling,
likelihood ratio tests provide strong support for the genetic
models (Table 4), with the dominant model being the most
parsimonious. Large standard errors were also noted in the
genotype offsets for the general model, again reflecting the
presence of few affected homozygotes. Finally, the presence of
gender-specific transmission and penetrance parameters suggest
360 J.C. Phillips et al. / Genomics 90 (2007) 354–363a mixed model of inheritance rather than a true autosomal
dominant. However, one could argue that it is quite common to
identify autosomal dominant traits that exhibit clear sex
predilections [26–28]. As discussed previously, a possible
origin for these gender-specific parameters is the selective
“early” death of unaffected male dogs. This early death
hypothesis could be stringently tested by applying an age-de-
pendent penetrance function in segregation analysis. This
function would serve to correct for the death of young
unaffected dogs. However, age-dependent penetrance functions
are not an option in either the jPAP or the MENDEL software
package.
Segregation analysis and linear modeling also allowed for
allele frequency and penetrance estimation. The methodology
used for this estimation differs between the software packages
jPAP and MENDEL, each having different theoretical methods
and specific constraints [15,16]. Regardless, parameter esti-
mates in both segregation analysis and linear modeling are fairly
consistent; attesting to the robustness of this dataset. Differ-
ences in ousiotype-specific penetrance (βAA, βAB, βBB) with
each approach were within parameter measurement errors.
Allele frequency (qA) estimates from segregation analysis and
linear modeling ranged from 0.12 to 0.13 (±0.02), while
penetrance (βij) estimates ranged from 72 to 77% and 90 to 99%
for males and females, respectively.
The allele frequency values estimated here are likely higher
than those found in the general deerhound population, directly
reflecting the ascertainment process used herein. The families
selected for analysis were identified using a sequential process
that greatly enriches the number of affected individuals [29].
Ascertainment correction was then applied by conditioning on
the proband's phenotype. This is a common procedure used in
pedigree analysis [30]. Strictly speaking, however, conditioning
on a proband's phenotype results in a correct formulation of the
likelihood only in cases of single ascertainment [14]. Single
ascertainment is rarely an appropriate model in animal genetics
(and to some extent in humans) given the finite population sizes
and presence of inbreeding. There are more robust approximate
methods for ascertainment correction; however, these methods
have not been incorporated into any software applicable to the
population described here [30].
When considering the apparent “intractability” of the ascer-
tainment problem, it is important to realize that its largest impact
in this case is on allele frequencies; penetrance and transmission
parameters are likely more consistent both within this popula-
tion and for the breed as a whole. These estimates were based on
314 sequentially collected nuclear families. Based on AKC
registrations, this collection represents ∼21% of all dogs
registered between the years 1975 and 2003. Given the small
population size of the Scottish deerhound and the ascertainment
process, it is probable that the majority of affected dogs (i.e.,
transmission events) were observed, which argues for more
reliable segregation ratios, penetrance estimates, and transmis-
sion parameters.
Elston et al. [31] developed three criteria that must be
satisfied before accepting a major genetic locus model. (1) The
data must show that a mixture of two distributions fits the datasignificantly better than one distribution. (2) Statistical
comparison of the general and the Mendelian models must be
nonsignificant. (3) Comparison of the general and environ-
mental models must be significant. Variance components
analysis (Table 2) demonstrated the first criterion by showing
that a mixture of two distributions (Model 3) described the
phenotypic variance in this population significantly better than
one distribution (Model 2). The second and third criteria were
fulfilled by segregation analysis; the likelihood ratio test
between the general model and the Mendelian models is
nonsignificant and the environmental model was statistically
rejected against the general model.
By fulfilling the Elston criteria, this population of dogs
represents only the second large-animal model for an inherited
cancer syndrome. The first documented heritable cancer
syndrome, renal cystadenocarcinoma (RCND), is seen almost
exclusively within the German shepherd dog [32]. The RCND
phenotype appears to segregate in an autosomal dominant
fashion with high penetrance and is caused by mutations within
the canine homologue of the human Birt-Hogg-Dube gene [33].
Other likely heritable cancer syndromes seen in large animals
include osteosarcoma in the Rottweiler [12], malignant
histiocytosis in the Bernese mountain dog [34], and lymphoma
in a variety of breeds [35]. While both osteosarcoma in the
Rottweiler and lymphoma in certain breeds represent excellent
spontaneous models for the homologous disease in humans, no
studies to date have documented the mode of inheritance or
genetic basis for any of these heritable malignancies.
The osteosarcoma phenotype segregating within this deer-
hound population shows strong similarity to the human
counterpart of primary bone osteosarcoma. In addition, the
trait exhibits a well-defined Mendelian inheritance, prescribed
risk factors, and a rapid clinical course among affected dogs.
This deerhound population thus represents an excellent
(spontaneously occurring) large-animal model of human
osteosarcoma. Significant public interest has focused on the
use of such companion animal models for the characterization
of novel therapeutics [36] and the delineation of genetic
mechanisms underlying cancer. Dogs are uniquely suited to
such studies because they share a common environment and
have shorter life expectancies than their human companions.
The shorter life expectancy would of course allow for more
rapid endpoint determination for any interventional study.
Genetic analysis of this population of deerhounds, through
linkage and/or association studies, will thus be extremely useful
for studying the molecular basis of this malignancy in both dogs
and humans.
Materials and methods
Sample population
Dogs used in this study were all privately owned and AKC registered
Scottish deerhounds ranging from 6 months to 15 years of age. Pedigrees were
constructed around 5 distantly related (more than three generations separated)
affected dogs ascertained as part of a prospective cohort design deerhound
health study [5]. Health information on all first-degree relatives of these 5
probands was ascertained. A sequential-sampling method [14] was then used to
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pedigrees contained approximately four generations of AKC-registered
ancestors of the original 5 probands. Through this combination of fixed and
sequential sampling, information on a total of 1057 dogs alive between the
years 1975 and 2003 was collected. Based on covariates (age, gender, height,
and weight), this population did not differ significantly from a previously
described randomly collected group of deerhounds [5]. Using AKC pedigree
information, this entire collection of 1057 deerhounds was grouped into one
large nondisjoint pedigree.
Pedigree information was obtained from either owners or breeders and
confirmed using the AKC pedigree certificates. Current and historic health
information on all dogs was collected from owners, breeders, and veterinarians.
Affected status was determined by the presence of characteristic radiographic
findings of aggressive bone disease and/or histologic examination. Pedigree
information and medical histories were entered into a pedigree management
program (Cyrillic 2.1.3; Cherwell Software). For construction of comprehensive
pedigrees, additional dogs who, in some cases, lacked complementary health
information were included.
Health information collected included a variety of qualitative and
quantitative traits (i.e., covariates). Qualitative traits included OSA status,
presence/absence of other diseases including cancers, and gender. OSA status
had three possible outcomes: affected, unaffected, or unknown. Quantitative
traits included age at exam, age of onset, height, weight, and length of time
sexually intact (as a measure of cumulative sex hormone exposure). Age at exam
was considered to be the age at last known contact or age at death where
applicable. Age of onset documented the age at which definitive diagnosis of
osteosarcoma was made in affected individuals. Time was measured in years,
height in inches at the shoulder, and weight in pounds. Other information
collected (where applicable) included cause of death, tumor location, and
treatment option.
Statistical analyses
Population descriptors, estimates of heritability, segregation analysis, and
linear modeling were obtained from analysis of the deerhound population in
which osteosarcoma segregates. Osteosarcoma was considered a dichot-
omous trait in which individuals were classified as “unaffected” (at the time
of exam) or “affected” or, in some cases, of “unknown status.” Disease
phenotypes of individuals with traits listed as “unknown” were ignored for
each analysis. Furthermore, individuals with missing covariates did not
contribute to covariate analysis. To adjust for the nonrandom nature of
proband selection, ascertainment correction was applied by conditioning the
sample likelihood on proband phenotype as described in each software
package [15,16].
Descriptive analysis
The program PEDINFO was used to determine descriptive characteristics
of the population. This program is available as a component of the genetic
analysis package SAGE 5.2.0 [17]. Inbreeding coefficients were estimated
using the Kinship Matrices option of the genetic software MENDEL 6.01
[16].
Heritability
Heritability (h2) in the narrow sense represents the proportion of total
(normally distributed) phenotypic variation that is due to genetics, or h2=σ2a/
(σ2a + σ
2
e), where σ
2
a is the additive (polygenic) variance and σ
2
e is the variance
due to individual-specific environmental effects [18]. The dominant (non-
additive) effects of a single allele can be accommodated by adding a dominance
variance (σ2d) to the above model. Estimation of heritability and the individual
components was performed by the method of variance components analysis.
Extending this method to large complex pedigrees and dichotomous
(binomially distributed) phenotypes, as described herein, can be done by
assuming that each individual belongs to a specific affection status if an
underlying genetically determined risk (i.e., liability) exceeds a certain
threshold. This latent “liability” is assumed to have an underlying multivariatenormal distribution. In addition to the variance components, covariate effects
were included in the model. Both variance components and covariate effects
were estimated, simultaneously, by maximum likelihood techniques. Binary
covariates were constrained to sum to zero; quantitative covariates had no such
restraint. Calculations were performed using an enhanced version of the variance
component program FISHER [19] as implemented in the heritability func-
tionality of MENDEL 6.01 [16].
Segregation analysis
Complex segregation analysis of the osteosarcoma trait was carried out
using the computer program jPAP version 1.4.0 beta [15]. A complete
description of this method using the PAP package has been described [20].
This program is currently the only available program for the segregation
analysis of discrete (qualitative) traits that allows the presence of inbreeding
loops. Computational time, however, increases dramatically as the complexity
of the pedigree increases. The complexity of this pedigree necessitated its
division into the five originally ascertained pedigrees for both segregation
analysis and linear modeling. This grouping was not a genetic or statistical
requirement; rather a computational requirement, due to the known limitations
of currently available software [15–17]. The effects of this necessary pedigree
division were expected to make the detection of a major locus more difficult
due to the loss of genetic information contained within the disrupted rela-
tionships. The magnitude of this effect cannot be estimated but was assumed to
be minor.
In segregation analysis, five single-locus transmission models were
evaluated, including Environmental, Mendelian dominant, Mendelian reces-
sive, Mendelian codominant, and Major locus arbitrary transmission (general
model). For completeness, a No major gene (sporadic) model was also
included. The five transmission models are postulated by allowing the presence
of three observable types with three corresponding transmission parameters.
The observable genotypes (or more properly “ousiotypes”) at this single major
locus were considered to be products of two alleles, A and B. Allele A is
considered the disease-associated allele, while allele B is considered the wild-
type allele. Six gender-specific transmission probabilities (ôAA, ôAB, ôBB),
which represent the probability that an individual of a given genotype will
transmit the A allele to his/her offspring, were assumed. Allele frequencies (qA
and qB) and six gender-specific penetrances (βAA, βAB, and βBB for females
and males individually) were estimated. The jPAP software, as a component of
its genetic model, allows for variations within the normal densities of each
genotype (i.e., a mixed model). These additional within-genotype parameters
were modeled as variance components and were estimated for the general
model.
Each model of transmission stated above was created by placing
appropriate restrictions on the ousiotypes and/or the transmission probabil-
ities. The Environmental model is the most restricted model and assumes no
transmission of major gene effect and the presence of three normally
distributed ousiotypes. This model is generated by equating the allele fre-
quency with a common transmission probability (τAA=τAB=τBB). The
Mendelian models assume the presence of a major locus, multiple (two or
three) ousiotypes, and transmission probabilities fixed at their Mendelian
expectations (τAA=0.0, τAB=0.5, τBB=1.0). Dominant, recessive, and
codominant expressions in the Mendelian model are created by placing
appropriate restrictions on the penetrances. Codominant expression allows
for three different genotypes that are not necessarily additive. The un-
restricted single-locus model (general model) includes three normally
distributed ousiotypes, assumed to occur in Hardy–Weinberg proportions,
and transmission probabilities estimated with the restriction of generational
equilibrium of trait distribution. This restriction of generational equilibrium
is, of course, an assumption of the Mendelian and Environmental models
and corresponds to
p ¼ p2s1 þ 2pqs2 þ q2s3:
A more general model with arbitrary transmission parameters failed to
converge in these data. Finally, in the sporadic model, disease penetrance is not
influenced by ousiotype and thus all individuals have the same inherent gender-
specific risk for disease development. Maximum likelihood procedures were
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Generalized linear modeling
While the program package jPAP does include a within-genotype parameter,
it does not allow for the direct inclusion of individual covariates that modify
traits. Therefore, to determine the effects of individual covariates on phenotype,
a generalized linear model [21] was used. This model is implemented in the
Penetrance Estimation option of the computer software programMENDEL 6.01
[16]. A generalized linear model allows for the estimation of affection pro-
bability. Assumptions include the presence of a set of predictors that modify
affection, a binomial distribution of the dependent variable (affected status), and
Mendelian transmission of genotype. Under a binomial distribution, the basic
formula for this regressive model is
AAA ¼ ey=ð1þ eyÞ;
where μAA is the affection probability of an individual with genotype AA and y
is a linear equation composed of an intercept (GRAND) and parameters for each
independent covariate. Maximum likelihood procedures are used to estimate the
intercept and coefficients for each covariate. Tests for genetic control can be
implemented through the addition of two or more covariates to represent
genotypes (AA, AB, BB), with appropriate constraints on their boundaries to
reflect recessive, dominant, or codominant (genotypic) transmission. Compar-
ison of the models with and without covariates allows for hypothesis testing.
Hypothesis testing
The Student t test was used to compare population means of descriptive
data. The LRT was used to test each submodel, in heritability analysis,
segregation analysis, and logistic regression, against the more general models.
This ratio is computed as minus twice the natural log-likelihood of the general
model subtracted from that for a restricted submodel, −2 ln(L1 − L0). This
difference is typically asymptotically distributed as aχ2 with degrees of freedom
equal to the difference in the number of independent parameters estimated in the
two models. Another method to compare models uses AIC, defined as AIC=−2
ln(L) + 2(number of parameters estimated). The most parsimonious model has
the minimum AIC value [22].Acknowledgments
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